oAlert.pl

Recalled Medicines & supplements – Current GIS Alerts 2026

Found 713 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.

Common hazards in this category

All recalled products

Bupivacaine Hydrochloride in Dextrose Injection USP – recalled product

Bupivacaine Hydrochloride in Dextrose Injection USP

CRITICAL 10.01.2023

The defective ampoule may crumble, creating a risk of glass particles entering the anaesthetic solution administered to the patient and of being unable to use the medicine during surgery. Potential effects: tissue damage from glass, surgical complications, life-threatening risk, lack of effective anaesthesia.

Allergovit – recalled product

Allergovit

CRITICAL 10.01.2023

Because there is a risk of misleading medical staff and, consequently, the patient receiving too high a dose of the drug, which may result in a threat to patients’ life and health. Potential effects: life‑threatening reactions, severe allergic reactions, serious complications of therapy.

HERBS, Thyme and Coltsfoot – recalled product

HERBS, Thyme and Coltsfoot

CRITICAL 30.12.2022

Exceeded permissible level of pyrrolizidine alkaloids in the dietary supplement (batch 31722). Potential effects: liver damage, toxicity with prolonged consumption.

BOOSTERON HARDCORE TESTOSTERONE BOOSTER (120 capsules) – recalled product

BOOSTERON HARDCORE TESTOSTERONE BOOSTER (120 capsules)

HIGH 14.12.2022

Presence of undeclared substances: yohimbine and ibutamoren, which may cause serious adverse effects and hormonal disturbances. Potential effects: adverse reactions, heart rhythm disorders, hypertension, hormonal disturbances.

MMASTER Raspberry – pre-workout supplement – recalled product

MMASTER Raspberry – pre-workout supplement

HIGH 13.12.2022

Presence of undeclared yohimbine — an alkaloid from yohimbe bark banned in food. Potential effects: cardiovascular disturbances, hypertension, tachycardia, neuropsychiatric symptoms, risk of poisoning.

Allergovit – recalled product

Allergovit

CRITICAL 09.12.2022

Incorrect labeling of vials (concentration A-1000 TU/ml labeled as B-10,000 TU/ml) may mislead medical staff and result in administering too high a dose, endangering patients’ life and health. Potential effects: overdose, severe allergic reactions, serious complications, life-threatening conditions.

Bisoratio ASA – recalled product

Bisoratio ASA

MEDIUM 07.12.2022

An out-of-specification result was found in stability testing for the parameter bisoprolol fumarate related substances: another single impurity. The probability of adverse reactions after exposure to the product cannot be excluded. Potential effects: possible adverse reactions, including toxic symptoms or reduced treatment efficacy.

Rivanol 0,1% – recalled product

Rivanol 0,1%

CRITICAL 05.12.2022

An out-of-specification pH value was detected, which may affect the antibacterial activity of ethacridine. A defective series of glass bottles is the probable cause, and pH changes until expiry are unpredictable. Potential effects: lack of treatment efficacy, possible complications of infections.

Cernevit – recalled product

Cernevit

CRITICAL 29.11.2022

An abnormal color of the solution after preparation was found, which may result from leaks caused by scratches on vial necks and lead to increased organic impurities or degradation products exceeding toxicological qualifications. Potential effects: toxic drug effects, parenteral complications, risk to patient health.

Tobramycin B. Braun – recalled product

Tobramycin B. Braun

CRITICAL 17.11.2022

It showed an out-of-specification result for the solution colour parameter. The product risk was assessed as RAS class II. Potential effects: possible reduced medicinal product quality, risk of treatment inefficacy or adverse reactions.

TESTOLONE – recalled product

TESTOLONE

HIGH 16.11.2022

Presence of undeclared ostarine and ibutamoren; declared RAD-140 not detected is also banned. Potential effects: pharmacological effects and adverse reactions.

BOSS Energy, dietary supplement – recalled product

BOSS Energy, dietary supplement

HIGH 10.11.2022

Presence of sildenafil and tadalafil, pharmacologically active substances not permitted in dietary supplements. Potential effects: pharmacological adverse effects, drug interactions, and risk to people with cardiac conditions.

Anacaps Expert – recalled product

Anacaps Expert

CRITICAL 28.10.2022

Possible contamination by glass particles in one of the product's ingredients. Potential effects: injuries to the mouth and gastrointestinal tract, risk of cuts and complications.

Fluorouracil Accord – recalled product

Fluorouracil Accord

CRITICAL 14.10.2022

Contaminants were detected in vials of batch P2108035, indicating possible non-compliance with quality requirements and a potential risk to patients’ health. Potential effects: treatment complications, infections, lack of therapeutic efficacy.

Mupina – recalled product

Mupina

HIGH 06.10.2022

detection during stability studies of out-of-specification results regarding an unknown impurity… it cannot be ruled out that keeping this product on the market may pose a risk to patient health. Potential effects: unknown adverse reactions, possible risk to patients’ health.

Menaright Forte, Phytomenadion Injection 2mg/0,2 ml – recalled product

Menaright Forte, Phytomenadion Injection 2mg/0,2 ml

CRITICAL 01.09.2022

The glass container shatters when opened, leaving glass fragments in the fingers and inside the ampoule, and differences in the solution volume in ampoules were found. Potential effects: injuries, glass foreign bodies, complications after injection, incorrect drug dose, life‑threatening events.

tianDe Phytotea with Angelica Sinensis and Salvia, 60g – recalled product

tianDe Phytotea with Angelica Sinensis and Salvia, 60g

HIGH 24.08.2022

Chlorpyrifos detected – pesticide residue exceeding the permissible level; substance harmful to health. Potential effects: poisoning, neurological disorders.

Heviran – recalled product

Heviran

HIGH 22.07.2022

A quality defect was found consisting in placing, in some packs of Heviran 400 mg film-coated tablets, a package leaflet in Lithuanian intended for Furosemid Polpharma 40 mg tablets. Potential effects: improper use of the medicine, lack of correct information on dosage, adverse reactions and precautions.

Amiodaron Hameln – recalled product

Amiodaron Hameln

CRITICAL 19.07.2022

Increased crystallization of the product was found in the concentrate for solution for injection or infusion, which may affect the safety and efficacy of intravenous administration. Potential effects: vascular embolism, lack of treatment efficacy, intravenous complications.

Vitaminum C Teva – recalled product

Vitaminum C Teva

CRITICAL 19.07.2022

A result outside specification limits was found for the parameter particles visible to the naked eye in an intramuscular or intravenous injection solution, which may pose a direct risk to patients’ health or life. Potential effects: embolism, inflammatory reactions, circulatory complications.

What to do if you bought a recalled product?

If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.